Raulli R
Cell Biology Laboratory, Jerome Holland Laboratory, American Red Cross, Rockville, MD 20853, USA.
J Pharm Pharmacol. 1998 Jan;50(1):75-82. doi: 10.1111/j.2042-7158.1998.tb03308.x.
The profile of nitric oxide (NO) release from the diazeniumdiolate class of NO donors was evaluated using inhibition of platelet aggregation as a model. At 37 degrees C, the NO complexes (Z)-1-¿N-methyl-N-[6-(N-methylammoniohexyl)amino]¿-diazen-1- ium-1,2-diolate (dimethylhexanediamine complex), sodium (Z)-1-(N,N-diethylamino)diazen-1-ium-1,2-diolate (diethylamine complex), (Z)-1-¿N-[3-aminopropyl]-N-[4-(3-aminopropylammonio)butyl]amino diazen-1-ium-1,2-diolate (spermine complex), and (Z)-1-[N-(2-aminoethyl)-N-(2-ammonioethyl)amino]diazen-1- ium-1,2-diolate (diethylenetriamine complex) have half-lives of 1, 2 and 39 min, and 20 h, respectively. All the diazeniumdiolates caused concentration-dependent inhibition of platelet aggregation; IC50 values (values for which the effect was half the maximum) were 26.0+/-24.1, 34.9+/-24.0 and 14.9+/-6.4 nM for dimethylhexanediamine complex, diethylamine complex and spermine complex, respectively, when pre-incubated with platelets for one half-life. Inhibition by all compounds was time-dependent. Pretreatment of platelets with spermine complex for 5 and 39 min resulted in IC50 values of 1.7+/-0.85 microM and 19.7+/-0.12 nM, whereas IC50 values for sodium nitroprusside were 27.3+/-1.25 nM and 25 nM (average, n = 2), at 5 and 39 min, respectively. Pre-incubation of each diazeniumdiolate at a concentration of 100 nM for 5 min at 37 degrees C, which resulted in the theoretical delivery of NO loads from 96.9% down to 0.3%, resulted in decreasingly efficacious inhibition of platelet aggregation. Linear regression analysis of the theoretical NO load delivered against the actual maximum inhibition (%) showed a strong correlation (r2 = 0.975). All four diazeniumdiolates caused concentration- and time-dependent inhibition of agonist-stimulated elevation of intra-platelet Ca2+ levels; IC50 values were, respectively, 8.7+/-1.49 nM and 11.5+/-1.36 nM for dimethylhexanediamine complex and diethylamine complex at their half-lives, and 176+/-16.9 nM and >100 microM, for spermine complex and diethylenetriamine complex at 2 min pre-incubation time. The respective nucleophiles not complexed with NO did not show anti-aggregatory properties or inhibition of agonist-induced elevation of intra-platelet Ca2+ levels. The inhibitory effects of all diazeniumdiolates tested were attenuated by 10 microM haemoglobin. These studies indicate that these compounds induce controlled, predictable release of NO at biological pH and temperature.
以抑制血小板聚集为模型,评估了重氮二醇盐类一氧化氮(NO)供体释放NO的情况。在37℃下,NO复合物(Z)-1-{N-甲基-N-[6-(N-甲基铵己基)氨基]}-重氮-1-鎓-1,2-二醇盐(二甲基己二胺复合物)、(Z)-1-(N,N-二乙氨基)重氮-1-鎓-1,2-二醇盐钠(二乙胺复合物)、(Z)-1-{N-[3-氨丙基]-N-[4-(3-氨丙基铵)丁基]氨基}重氮-1-鎓-1,2-二醇盐(精胺复合物)和(Z)-1-[N-(2-氨乙基)-N-(2-铵乙基)氨基]重氮-1-鎓-1,2-二醇盐(二乙烯三胺复合物)的半衰期分别为1分钟、2分钟、39分钟和20小时。所有重氮二醇盐均引起血小板聚集的浓度依赖性抑制;与血小板预孵育一个半衰期时,二甲基己二胺复合物、二乙胺复合物和精胺复合物的IC50值(效应为最大值一半时的值)分别为26.0±24.1、34.9±24.0和14.9±6.4 nM。所有化合物的抑制作用均呈时间依赖性。用精胺复合物预处理血小板5分钟和39分钟时,IC50值分别为1.7±0.85μM和19.7±0.12 nM,而硝普钠在5分钟和39分钟时的IC50值分别为27.3±1.25 nM和25 nM(平均值,n = 2)。在37℃下,将每种重氮二醇盐以100 nM的浓度预孵育5分钟,这导致理论上NO负载量从96.9%降至0.3%,血小板聚集抑制效果逐渐减弱。对理论释放的NO负载量与实际最大抑制率(%)进行线性回归分析,显示出很强的相关性(r2 = 0.975)。所有四种重氮二醇盐均引起激动剂刺激的血小板内Ca2+水平升高的浓度和时间依赖性抑制;二甲基己二胺复合物和二乙胺复合物在其半衰期时的IC50值分别为8.7±1.49 nM和11.5±1.36 nM,精胺复合物和二乙烯三胺复合物在预孵育2分钟时的IC50值分别为176±16.9 nM和>100μM。未与NO络合的相应亲核试剂未表现出抗聚集特性或抑制激动剂诱导的血小板内Ca2+水平升高。所有测试的重氮二醇盐的抑制作用均被10μM血红蛋白减弱。这些研究表明,这些化合物在生理pH和温度下诱导NO的可控、可预测释放。